Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 3:33 pm Sale |
2022-12-31 | 13G | HTG Molecular Diagnostics, Inc. HTGM |
LYTTON LAURENCE W | 0 0.000% |
-43,474 (Position Closed) |
Filing History |
| 2023-02-10 09:03 am Sale |
2022-12-31 | 13G | HTG Molecular Diagnostics, Inc. HTGM |
Samjo Capital LLC | 0 0.000% |
-51,258 (Position Closed) |
Filing History |
| 2023-02-03 4:02 pm Sale |
2022-12-31 | 13G | HTG Molecular Diagnostics, Inc. HTGM |
Cowen Prime Advisors LLC | 0 0.000% |
-49,428 (Position Closed) |
Filing History |
| 2022-12-07 06:01 am Sale |
2022-12-06 | 13D | HTG Molecular Diagnostics, Inc. HTGM |
Hyperscale Data Inc. GPUS |
39,167 4.250% |
-27,500 (-41.25%) |
Filing History |
| 2022-12-02 4:30 pm Sale |
2022-11-30 | 13D | HTG Molecular Diagnostics, Inc. HTGM |
Hyperscale Data Inc. GPUS |
66,667 7.240% |
-25,000 (-27.27%) |
Filing History |
| 2022-08-05 06:01 am Purchase |
2022-07-26 | 13D | HTG Molecular Diagnostics, Inc. HTGM |
Hyperscale Data Inc. GPUS |
91,667 9.960% |
91,667 (New Position) |
Filing History |
| 2022-07-28 1:06 pm Sale |
2022-07-28 | 13G | HTG Molecular Diagnostics, Inc. HTGM |
The Hewlett Fund LP | 2,083 0.226% |
-41,574 (-95.23%) |
Filing History |
| 2022-07-18 09:00 am Purchase |
2022-07-18 | 13G | HTG Molecular Diagnostics, Inc. HTGM |
L5 Capital Inc. | 97,500 10.590% |
47,500 (+95.00%) |
Filing History |
| 2022-06-29 09:00 am Purchase |
2022-06-28 | 13G | HTG Molecular Diagnostics, Inc. HTGM |
L5 Capital Inc. | 50,000 5.400% |
50,000 (New Position) |
Filing History |
| 2022-03-31 4:05 pm Sale |
2022-03-21 | 13G | HTG Molecular Diagnostics, Inc. HTGM |
Orin Hirschman | 0 0.000% |
-51,167 (Position Closed) |
Filing History |
| 2022-02-15 2:16 pm Purchase |
2021-12-31 | 13G | HTG Molecular Diagnostics, Inc. HTGM |
LYTTON LAURENCE W | 43,474 6.800% |
3,107 (+7.70%) |
Filing History |
| 2022-02-14 08:15 am Sale |
2021-12-31 | 13G | HTG Molecular Diagnostics, Inc. HTGM |
Nantahala Capital Management, LLC | 27,918 4.400% |
-2,384 (-7.87%) |
Filing History |
| 2022-02-11 3:36 pm Purchase |
2021-12-31 | 13G | HTG Molecular Diagnostics, Inc. HTGM |
Orin Hirschman | 51,167 11.000% |
167 (+0.33%) |
Filing History |
| 2022-02-09 12:34 pm Purchase |
2021-12-31 | 13G | HTG Molecular Diagnostics, Inc. HTGM |
Cowen Prime Advisors LLC | 49,428 8.000% |
49,428 (New Position) |
Filing History |
| 2022-02-08 1:57 pm Purchase |
2021-12-31 | 13G | HTG Molecular Diagnostics, Inc. HTGM |
Samjo Capital LLC | 51,258 8.100% |
51,258 (New Position) |
Filing History |
| 2022-01-04 11:30 am Purchase |
2021-12-31 | 13G | HTG Molecular Diagnostics, Inc. HTGM |
The Hewlett Fund LP | 43,657 6.923% |
9,583 (+28.13%) |
Filing History |
| 2021-06-30 09:24 am Purchase |
2021-06-29 | 13G | HTG Molecular Diagnostics, Inc. HTGM |
The Hewlett Fund LP | 34,074 5.640% |
34,074 (New Position) |
Filing History |
| 2021-06-07 06:22 am Purchase |
2021-06-03 | 13G | HTG Molecular Diagnostics, Inc. HTGM |
Orin Hirschman | 51,000 11.000% |
51,000 (New Position) |
Filing History |
| 2021-02-16 11:37 am Purchase |
2020-12-31 | 13G | HTG Molecular Diagnostics, Inc. HTGM |
LYTTON LAURENCE W | 40,368 9.990% |
40,368 (New Position) |
Filing History |
| 2021-02-16 06:23 am Purchase |
2020-12-31 | 13G | HTG Molecular Diagnostics, Inc. HTGM |
Nantahala Capital Management, LLC | 30,302 7.700% |
30,302 (New Position) |
Filing History |